跳至主要内容
临床试验/NCT00522782
NCT00522782已完成4 期

Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma

AAADRS Clinical Research Center1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2007年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
16
试验地点
1
主要终点
Exhaled breath nitric oxide pre- to post treatment

研究概览

简要总结

To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.

详细描述

Comparisons will be made before and after 2 week therapy of nebulized budesonide in children not on prior anti-inflammatory medications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
4 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Asthma diagnosis previously for 6 months
  • Past asthma medication without change for previous 6 months
  • Increased NO levels and ability to perform maneuver
  • ICF signed by parents

排除标准

  • Systemic steroids in past 60 days,inhaled/nebulized steroids in past 4 weeks
  • Hospitalization within 3 months
  • Upper or lower airways active infection or cigarette smoke direct exposure
  • Use of other asthma medications other than bronchodilators one month prior and during the trial
  • Noncompliance

研究组 & 干预措施

A

Active Comparator

Nebulized budesonide

干预措施: Nebulized Budesonide (Drug)

A

Active Comparator

Nebulized budesonide

干预措施: Nitric Oxide Analyzer (Device)

结局指标

主要结局

Exhaled breath nitric oxide pre- to post treatment

时间窗: two weeks

次要结局

  • Spirometry with peak flow measurements and daily diary scores(two weeks)

研究者

发起方
AAADRS Clinical Research Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验